Headquarters
755 SHERIDAN RD, WINNETKA, IL 60093-2309, US
WINNETKA, IL, US
AKAVA THERAPEUTICS INC
From the company
AKAVA Therapeutics is a biotechnology company developing first-in-class small molecule inhibition therapeutics for neurodegenerative diseases and cancers. Its lead compound AKV9 targets protein aggregation and has been investigated in ALS, hereditary spastic paraplegia, frontotemporal dementia, and Alzheimer's disease. The company was established in 2019 as a commercialization arm for compounds from the Silverman Laboratory at Northwestern University.
Products & services offered
Capabilities 3
Classifications
- Ownership classifications (1)
- Veteran Owned Business
Facilities
Send your requirements
Quantities, certifications, and timing.